Display options
Cite
Pentecost A, Kim MJ, Jeon S, et al. Immunomodulatory nanodiamond aggregate-based platform for the treatment of rheumatoid arthritis. Regen Biomater. 2019;6(3):163-174doi: 10.1093/rb/rbz012.
Pentecost, A., Kim, M. J., Jeon, S., Ko, Y. J., Kwon, I. C., Gogotsi, Y., Kim, K., & Spiller, K. L. (2019). Immunomodulatory nanodiamond aggregate-based platform for the treatment of rheumatoid arthritis. Regenerative biomaterials, 6(3), 163-174. https://doi.org/10.1093/rb/rbz012
Pentecost, Amanda, et al. "Immunomodulatory nanodiamond aggregate-based platform for the treatment of rheumatoid arthritis." Regenerative biomaterials vol. 6,3 (2019): 163-174. doi: https://doi.org/10.1093/rb/rbz012
Pentecost A, Kim MJ, Jeon S, Ko YJ, Kwon IC, Gogotsi Y, Kim K, Spiller KL. Immunomodulatory nanodiamond aggregate-based platform for the treatment of rheumatoid arthritis. Regen Biomater. 2019 Jun;6(3):163-174. doi: 10.1093/rb/rbz012. Epub 2019 Apr 19. PMID: 31198584; PMCID: PMC6547310.
Copy Download .nbib Format: NLM
Share it on

Regen Biomater. 2019 Jun;6(3):163-174. doi: 10.1093/rb/rbz012. Epub 2019 Apr 19.

Immunomodulatory nanodiamond aggregate-based platform for the treatment of rheumatoid arthritis.

Regenerative biomaterials

Amanda Pentecost, Min Ju Kim, Sangmin Jeon, Young Ji Ko, Ick Chan Kwon, Yury Gogotsi, Kwangmeyung Kim, Kara L Spiller

Affiliations

  1. Department of Materials Science and Engineering, College of Engineering, Drexel University, Philadelphia, PA, USA.
  2. School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, PA, USA.
  3. KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, South Korea.
  4. Biomedical Research Institute, Center for Theragnosis, Korea Institute of Science and Technology, Seoul, South Korea.

PMID: 31198584 PMCID: PMC6547310 DOI: 10.1093/rb/rbz012

Abstract

We previously demonstrated that octadecylamine-functionalized nanodiamond (ND-ODA) and dexamethasone (Dex)-adsorbed ND-ODA (ND-ODA-Dex) promoted anti-inflammatory and pro-regenerative behavior in human macrophages

Keywords: biomaterial–cell interaction; drug delivery; nanobiomaterials

References

  1. Ann Rheum Dis. 1999 Jan;58(1):49-54 - PubMed
  2. J Clin Invest. 2000 Dec;106(12):1481-8 - PubMed
  3. N Engl J Med. 2001 Oct 11;345(15):1098-104 - PubMed
  4. Arthritis Res Ther. 2004;6(1):R65-R72 - PubMed
  5. J Clin Invest. 1992 Sep;90(3):772-9 - PubMed
  6. Rheumatology (Oxford). 2004 Nov;43(11):1337-45 - PubMed
  7. Trends Immunol. 2004 Dec;25(12):677-86 - PubMed
  8. Scand J Immunol. 2005 Jan;61(1):10-7 - PubMed
  9. Biomaterials. 2005 Dec;26(34):6811-7 - PubMed
  10. J Am Chem Soc. 2006 Sep 6;128(35):11635-42 - PubMed
  11. FASEB J. 2006 Dec;20(14):2591-3 - PubMed
  12. J Immunol. 2006 Nov 15;177(10):7303-11 - PubMed
  13. J Phys Chem B. 2007 Jan 11;111(1):2-7 - PubMed
  14. Nat Clin Pract Rheumatol. 2007 Jan;3(1):26-34 - PubMed
  15. Nat Protoc. 2007;2(5):1269-75 - PubMed
  16. Annu Rev Pathol. 2008;3:99-126 - PubMed
  17. Scand J Immunol. 2008 Mar;67(3):304-12 - PubMed
  18. Pharm Res. 2008 Aug;25(8):1815-21 - PubMed
  19. Tissue Eng Part A. 2009 Jul;15(7):1687-94 - PubMed
  20. J Immunol. 1991 Oct 1;147(7):2187-95 - PubMed
  21. J Am Chem Soc. 2009 Apr 8;131(13):4594-5 - PubMed
  22. Arthritis Rheum. 1991 Sep;34(9):1125-32 - PubMed
  23. Eur J Immunol. 2009 Aug;39(8):2040-4 - PubMed
  24. Rheumatology (Oxford). 2011 Jan;50(1):124-31 - PubMed
  25. Arthritis Res Ther. 2010;12(4):R160 - PubMed
  26. Eur J Pharm Sci. 2010 Dec 23;41(5):650-7 - PubMed
  27. Int Immunopharmacol. 2011 Oct;11(10):1557-63 - PubMed
  28. Biomaterials. 2011 Dec;32(36):9810-7 - PubMed
  29. Nat Nanotechnol. 2011 Dec 18;7(1):11-23 - PubMed
  30. Mol Ther. 2012 Aug;20(8):1550-8 - PubMed
  31. Rheumatology (Oxford). 2012 Jul;51 Suppl 5:v3-11 - PubMed
  32. J Immunol. 2012 Oct 1;189(7):3669-80 - PubMed
  33. J Immunol. 2012 Oct 1;189(7):3508-20 - PubMed
  34. J Allergy Clin Immunol. 2013 Nov;132(5):1033-44 - PubMed
  35. Immunity. 2016 Mar 15;44(3):450-462 - PubMed
  36. J Control Release. 2016 May 28;230:64-72 - PubMed
  37. Exp Biol Med (Maywood). 2016 May;241(10):1054-63 - PubMed
  38. Nat Rev Rheumatol. 2016 Aug;12(8):472-85 - PubMed
  39. ACS Nano. 2016 Aug 23;10(8):7385-400 - PubMed
  40. Lancet. 2016 Oct 8;388(10053):1545-1602 - PubMed
  41. Mycoses. 2017 Apr;60(4):222-229 - PubMed
  42. Immunobiology. 2017 Jul;222(7):847-856 - PubMed
  43. Nanotechnology. 2017 Jun 23;28(25):252001 - PubMed
  44. Adv Drug Deliv Rev. 2017 Dec 1;122:74-83 - PubMed
  45. Biomater Sci. 2017 Sep 26;5(10):2131-2143 - PubMed
  46. Front Pharmacol. 2017 Nov 14;8:818 - PubMed
  47. Int J Pharm. 2018 Apr 5;540(1-2):57-64 - PubMed
  48. Nature. 1986 Feb 6-12;319(6053):516-8 - PubMed
  49. Eur J Immunol. 1981 Oct;11(10):805-15 - PubMed
  50. J Appl Physiol (1985). 1994 Jul;77(1):290-7 - PubMed
  51. Biochim Biophys Acta. 1994 Apr 20;1191(1):43-51 - PubMed
  52. Cell Immunol. 1993 Jun;149(1):39-49 - PubMed
  53. Arthritis Rheum. 1996 Jan;39(1):115-24 - PubMed
  54. Arthritis Rheum. 1997 Feb;40(2):217-25 - PubMed
  55. Immunology. 1997 Aug;91(4):548-52 - PubMed
  56. Clin Sci (Lond). 1998 Jun;94(6):557-72 - PubMed

Publication Types

Grant support